McLaughlin Gerald W. 4
4 · Neos Therapeutics, Inc. · Filed Jun 28, 2018
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-06-27+600,000→ 600,000 totalExercise: $6.20Exp: 2028-06-27→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]This stock option was granted pursuant to the Company's 2018 Inducement Plan and vests in equal annual installments over a four-year period which began on June 27, 2018.